A DOUBLE-BLINDED, RANDOMISED, TWO -PERIOD CROSSOVER EUGLYCEMIC CLAMP TRIAL INVESTIGATING THE PHARMACOKINETICS, GLUCODYNAMICS AND SAFETY OF BIOCHAPERONE INSULIN LISPRO AND INSULIN LISPRO (HUMALOG®) IN SUBJECTS WITH TYPE 1 DIABETES: